U.S. Stem Cell, Inc.
USRM
$0.0001
$0.000.00%
| 12/31/2022 | 09/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | 40.85% | -42.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 40.85% | -42.04% | |||
| Cost of Revenue | -7.55% | -14.52% | |||
| Gross Profit | 67.78% | -50.82% | |||
| SG&A Expenses | -4.02% | -10.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.04% | -10.62% | |||
| Operating Income | 5.65% | 8.83% | |||
| Income Before Tax | -0.21% | 0.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.21% | 0.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.21% | 0.82% | |||
| EBIT | 5.65% | 8.83% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | 10.00% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 0.00% | 10.00% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 4.18% | 2.02% | |||
| Average Diluted Shares Outstanding | 4.18% | 2.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
